GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MedMen Enterprises Inc (OTCPK:MMNFQ) » Definitions » Capex-to-Revenue

MedMen Enterprises (MedMen Enterprises) Capex-to-Revenue : -0.07 (As of Mar. 2023)


View and export this data going back to 2018. Start your Free Trial

What is MedMen Enterprises Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

MedMen Enterprises's Capital Expenditure for the three months ended in Mar. 2023 was $1.87 Mil. Its Revenue for the three months ended in Mar. 2023 was $27.23 Mil.

Hence, MedMen Enterprises's Capex-to-Revenue for the three months ended in Mar. 2023 was -0.07.


MedMen Enterprises Capex-to-Revenue Historical Data

The historical data trend for MedMen Enterprises's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMen Enterprises Capex-to-Revenue Chart

MedMen Enterprises Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.50 1.00 0.40 0.03 0.07

MedMen Enterprises Quarterly Data
Apr18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.06 0.22 - 0.20 -0.07

Competitive Comparison of MedMen Enterprises's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, MedMen Enterprises's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedMen Enterprises's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MedMen Enterprises's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where MedMen Enterprises's Capex-to-Revenue falls into.



MedMen Enterprises Capex-to-Revenue Calculation

MedMen Enterprises's Capex-to-Revenue for the fiscal year that ended in Jun. 2022 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-9.656) / 140.812
=0.07

MedMen Enterprises's Capex-to-Revenue for the quarter that ended in Mar. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (1.869) / 27.225
=-0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedMen Enterprises  (OTCPK:MMNFQ) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


MedMen Enterprises Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of MedMen Enterprises's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


MedMen Enterprises (MedMen Enterprises) Business Description

Traded in Other Exchanges
Address
10115 Jefferson Boulevard, Culver City, CA, USA, 90232
MedMen Enterprises Inc formerly known as Ladera Ventures Corp is the preeminent cannabis company with multiple assets and operations in California, Nevada, and New York, which combined account for nearly half of North America's addressable legal market. The company owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail.